SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010443
Filing Date
2024-04-05
Accepted
2024-04-05 17:37:30
Documents
1
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 form4-04052024_090425.html 4  
1 form4-04052024_090425.xml 4 3857
  Complete submission text file 0001415889-24-010443.txt   5298
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address
Pons Jaume (Reporting) CIK: 0001816977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39386 | Film No.: 24827611